`

AlloVir

Biotechnology Research

Specialities :
Cell therapy
Infectious disease
Therapeutic developer
And biotechnology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$75.0M
size-icon Size
11 - 50

Frequently Asked Questions About AlloVir

What does Allovir do?+

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The companys technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVirs technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product...

What are Allovir's specialties? +

Cell therapy,infectious disease,therapeutic developer,and biotechnology

What is Allovir's industry? +

Allovir operates in the Biotechnology research industry.

What is Allovir's revenue? +

Allovir's revenue is 11m - 100m

What is Allovir's company size? +

Allovir has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.